ABPI pres­i­dent steps down over No­vo Nordisk code of prac­tice breach

A No­vo Nordisk ex­ec has stepped down from his po­si­tion as pres­i­dent of the As­so­ci­a­tion of the British Phar­ma­ceu­ti­cal In­dus­try as his com­pa­ny faces ques­tions over the spon­sor­ship of we­bi­na­rs tout­ing its weight loss and di­a­betes treat­ment Sax­en­da.

Pin­der Sa­ho­ta, No­vo Nordisk’s gen­er­al man­ag­er UK, re­signed from the pres­i­den­cy last week to “avoid an on­go­ing process around a No­vo Nordisk ABPI code of prac­tice breach be­com­ing a dis­trac­tion from the vi­tal work of the ABPI.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER